Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
November 2025
The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy
Celemics partners with Strand Life Science to develop bioinformatics solutions
, /in E-News /by panglobalCelemics has partnered with Strand Life Sciences to develop a bioinformatics solution capable of providing users with an accelerated means of producing high-quality, in-class clinical genomics reports and enabling a complete sample-to-answer solution, including assayspecific variant filters.
Algorics acquires Domain Clinical Data Sciences
, /in E-News /by panglobalAlgorics, a provider of biostatistics and programming solutions for the pharmaceutical and biotechnology industry, has acquired Domain Clinical Data Sciences (DCDS), a clinical data services organisation based in India.
AMSBIO releases Adeno-Associated Virus reference materials
, /in Product News /by panglobalAMSBIO has unveiled a new range of AAV reference materials of full capsids and empty capsids of six different serotypes.
Investors inject €2 million into Abviris to boost HPV cancer biomarker expansion
, /in E-News /by panglobalAbviris Deutschland, a biotech company, has received an injection of €2 million from existing investors to speed up expansion. The move comes after the publication of highly promising results for its pioneering immunoassay biomarker as an aid in the early diagnosis of head, neck and anogenital cancers caused by human papilloma viruses (HPV).
Advances in point-of-care hematology analysis
, /in Featured Articles /by panglobalPoint-of-care hematology analysis can help to generate the data needed to make decisions about patient care quickly, both of which can improve patient outcomes in emergency situations and also help hospitals to meet waiting time targets safely. CLI asked Cleve Wright, Director of Medical HORIBA UK Ltd, about recent developments in this field.
Agilent announces new SureSelect Human All Exon V8
, /in Product News /by Agilent Technologies EuropeAgilent Technologies has released SureSelect Human All Exon V8 – a new exome design that provides comprehensive content and up-to-date coverage of protein-coding regions from RefSeq, CCDS, and GENCODE. It also covers the TERT promoter and hard-to-capture exons that are omitted by other exomes on the market. The new design is available in three options […]
Actim Oy antigen test for diagnosis of acute COVID-19 infection receives CE marking
, /in Product News /by 3wmediaThe Finnish diagnostics company Actim Oy has recently received a CE mark for the new Actim SARS-CoV-2 rapid test. The test is intended for healthcare professionals and it detects the nucleoprotein of SARS-CoV-2 virus in the nasopharyngeal swab sample. The test has been shown to perform reliably with different variants of the coronavirus, such as […]
Investigation of SARS-CoV-2-specific immune responses
, /in Featured Articles, Microbiology /by panglobalA thorough understanding of the immune response to SARS-CoV-2 is necessary for the evaluation of the efficacy of vaccines and vaccine candidates against this virus. This article discusses how some parts of the humoral and cellular immune responses can be analysed to improve our understanding of how the body reacts to this virus.
Bruker Corp launches two new timsTOF instruments
, /in Product News /by panglobalBruker Corporation has launched two new timsTOF instruments – the timsTOF SCP for unbiased single cell 4D-proteomics and the next-gen timsTOF Pro 2 with unprecedented proteomic depth. The instruments enable new applications and methods in unbiased proteomics, epiproteomics/PTM characterization, and unbiased, deep multiomic biomarker discovery, such as in cancer liquid biopsy research.
Enhanced performance
, /in Advertenties /by panglobal